Completed
This National Academies public workshop, which was co-hosted by the Forum on Drug Discovery, Development and Translation, and the Forum on Neuroscience and Nervous System Disorders, provided a venue for professionals who typically diagnose ADHD, drug developers, researchers, people with lived experience, and other stakeholders to discuss the diagnosis and treatment of adults with ADHD, explore challenges and opportunities for drug development, and consider strategies for assessing the risks and benefits of ADHD medication treatment in adult populations. The workshop was supported, in part, through a grant (PAR-23-072) from the Center for Drug Evaluation and Research at the FDA.
Featured publication
Workshop
ยท2024
Attention deficit/hyperactivity disorder (ADHD) diagnosis and treatment among adults has increased over the past decade in the U.S. and globally. Evidence suggests adults with ADHD may be more likely to develop a substance use disorder, and there are concerns that nonmedical use of prescription stim...
View details